Correction: Evidence and reality: an observational study on pharmacological outcomes in advanced head and neck tumors

Correction: Evidence and reality: an observational study on pharmacological outcomes in advanced head and neck tumors

Saved in:

Bibliographic Details
Main Authors:	Consuelo Jordán de Luna, Anna Esteve, Olalla Montero Pérez, Ana Clopés Estela, Marc Oliva, Alicia Lozano Borbalas, Ricard Mesía Nin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Oncology
Subjects:	HNSCC head and neck cancer real-life data treatment algorithms decision-making
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1677769/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evidence and reality: an observational study on pharmacological outcomes in advanced head and neck tumors
by: Consuelo Jordán de Luna, et al.
Published: (2025-07-01)

Salvage chemotherapy after progression on immunotherapy in recurrent/metastatic squamous cell head and neck carcinoma
by: Sandra Llop, et al.
Published: (2024-11-01)

Postoperative complications following salvage neck dissection after (chemo)radiotherapy for head and neck squamous cell carcinoma: which patients are at high risk?
by: Arash Navran, et al.
Published: (2025-05-01)

Strategies for Anticancer Treatment in p53-Mutated Head and Neck Squamous Cell Carcinoma
by: Bi-He Cai, et al.
Published: (2025-05-01)

Duchenne muscular dystrophy gene product expression is associated with survival in head and neck squamous cell carcinoma
by: Leanne Jones, et al.
Published: (2025-03-01)

Radiotherapy outcomes and risk factors for young patients with head-and-neck squamous cell carcinomas: a matched-pair analysis
by: Jiadai Zou, et al.
Published: (2025-04-01)

Cottontail Rabbit Papillomavirus (CRPV) Related Animal Models for Head and Neck Cancer Research: A Comprehensive Review of the Literature
by: Michael Bette, et al.
Published: (2024-10-01)

Nivolumab resistance in head and neck squamous cell carcinoma patients and future perspectives
by: Karolina Buchajska, et al.
Published: (2025-04-01)

Role of Human Papilloma Virus in Carcinogenesis of Head and Neck Squamous Cell
by: Sukri Rahman, et al.
Published: (2024-01-01)

Integrating metabolism gene clusters and tumor immune microenvironment in head and neck squamous cell carcinoma
by: Meina Lian, et al.
Published: (2025-06-01)

INDUCTION CHEMOTHERAPY IN ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA: A REAL-WORLD DATA STUDY
by: Matheus Yung Perin, et al.
Published: (2025-05-01)

Editorial: Early diagnosis in head and neck cancer: advances, techniques, and challenges
by: Natalia Koerich Laureano, et al.
Published: (2025-07-01)

A Single-Cell Transcriptome Atlas of Epithelial Subpopulations in HPV-Positive and HPV-Negative Head and Neck Cancers
by: Mary C. Bedard, et al.
Published: (2025-03-01)

Analysis of Selected Small Proline-Rich Proteins in Tissue Homogenates from Samples of Head and Neck Squamous Cell Carcinoma
by: Dariusz Nałęcz, et al.
Published: (2025-06-01)

Comprehensive bioinformatic profiling of matrix metalloproteinases and their inhibitors: Expression and interaction patterns in head and neck cancer toward predictive biomarkers and personalized therapies
by: Rishaba Byju, et al.
Published: (2024-09-01)

Oxidative Stress and Dietary Antioxidants in Head and Neck Cancer
by: A Jeong You, et al.
Published: (2025-04-01)

Peripheral immune and inflammatory markers as predictors of neoadjuvant immunotherapy response in head and neck squamous cell carcinoma
by: Wendi Li, et al.
Published: (2025-12-01)

Stereotactic body radiation therapy as initial treatment for head and neck cancer
by: Sivakamavalli Jeyachandran
Published: (2024-06-01)

Adverse event profile of five anti head and neck squamous cell carcinoma drugs: a descriptive analysis from WHO-VigiAccess
by: Weimin Gao, et al.
Published: (2025-06-01)

Pathological regression patterns following neoadjuvant chemo-immunotherapy in head and neck squamous cell carcinoma: a pilot study
by: Dikan Wang, et al.
Published: (2025-08-01)

Optimizing Prognostic Assessment in High‐Risk Head and Neck Squamous Cell Carcinomas: The Impact of Tumor Budding and a Novel Histomorphological Scoring System
by: Moritz Knebel, et al.
Published: (2025-02-01)

Prognostic value of lipid metabolism‐related genes in head and neck squamous cell carcinoma
by: Ying Xiong, et al.
Published: (2021-03-01)

Structured Early Follow-Up in Head and Neck Squamous Cell Carcinomas: A Retrospective Cohort Study
by: Philipp Dittmann, et al.
Published: (2025-05-01)

Oral health and the risk of head and neck squamous cell carcinoma: a multicenter case-control study in Iran
by: Hamideh Rashidian, et al.
Published: (2025-08-01)

Systematic analysis of chemotherapy, immunotherapy, and combination therapy in Head and Neck Squamous Cell Carcinoma (HNSCC) clinical trials: Focusing on overall survival and progression-free survival outcomes
by: Priya Ganesan, et al.
Published: (2024-12-01)

Epithelial-Mesenchymal Transition and Inflammation in Head and Neck Squamous Cell Carcinoma
by: Habib Sadeghi Rad, et al.
Published: (2020-04-01)

Inhibition of head and neck squamous cell carcinoma by Bruton’s tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells
by: Anna R. Bopp, et al.
Published: (2025-05-01)

Gene expression profiling and pathway analysis in head and neck squamous cell carcinoma: focus on disulfidptosis
by: Yajun Tong, et al.
Published: (2025-04-01)

Advances in neoantigen-based immunotherapy for head and neck squamous cell carcinoma: a comprehensive review
by: Manzhu Jiang, et al.
Published: (2025-05-01)

Analysis of divergent gene expression between HPV + and HPV- head and neck squamous cell carcinoma patients
by: Kasturika Shankar, et al.
Published: (2025-05-01)

30-hydroxygambogic acid increases the efficacy of cisplatin in an HPV+ head and neck cancer in vivo model
by: Sonia N. Whang, et al.
Published: (2025-08-01)

The characteristics and functional significance of disulfidptosis-related genes in head and neck squamous cell carcinoma
by: Haiqian Zhu, et al.
Published: (2024-12-01)

SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK: NEW AVENUES OF TREATMENT?
by: T. Braunschweig, et al.
Published: (2015-04-01)

Pathological mechanisms and advances in neoadjuvant PD-1 blockade combined with chemotherapy for head and neck cancer
by: Yun-jing Hou, et al.
Published: (2024-12-01)

A hypoxia‐related lncRNA model for prediction of head and neck squamous cell carcinoma prognosis
by: Junwei Xiang, et al.
Published: (2023-02-01)

VPS25 Promotes an Immunosuppressive Microenvironment in Head and Neck Squamous Cell Carcinoma
by: Li-Guo Chen, et al.
Published: (2025-02-01)

Neutrophil/lymphocyte ratio: a potential biomarker in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors
by: Marianna Caterino, et al.
Published: (2025-05-01)

TMCO1, as a potential biomarker of prognosis and immunotherapy response, regulates head and neck squamous cell carcinoma proliferation and migration
by: Ting Li, et al.
Published: (2025-05-01)

Positron emission tomography directed re-irradiation using volumetric modulated arc technique in recurrent head and neck squamous cell carcinoma
by: Sambit S. Nanda, et al.
Published: (2025-05-01)

Comprehensive analysis illustrating the role of HOXB8 in head and neck squamous cell carcinoma: evidence from multi-omics analysis and experiments validation
by: Jun-wei Zhang, et al.
Published: (2025-04-01)